U.S. health officials have warned for months that someone infected with Ebola could unknowingly carry the virus to this country, and there is word now that it has happened: A traveler in a Dallas hospital became the first patient diagnosed in the U.S.
Researchers have shown for the first time that a genetic switch allows Streptococcus pneumoniae to randomly change its characteristics into six alternative states.
On this episode of Bioscience Technology This Week, Christina Jakubowski covers mosquitoes infected with a dengue-blocking bacteria that have been released in Brazil. Our second story highlights new research that has restored natural walking ability in completely paralyzed rats.
U.S. mobile Ebola labs should be up and running in Liberia this week, and American troops have broken ground for a field hospital, as the international community races to increase the ability to care for the spiraling number of people infected with the dreaded disease.
An excruciating mosquito-borne illness that arrived less than a year ago in the Americas is raging across the region, leaping from the Caribbean to the Central and South American mainland, and infecting more than 1 million people.
Health officials are investigating nine cases of muscle weakness or paralysis in Colorado children and whether the culprit might be a virus causing severe respiratory illness across the country.
An American doctor who was exposed to the Ebola virus while volunteering in Sierra Leone has been admitted for observation at The National Institutes of Health near the nation's capital. NIH confirmed in a news release on its website that the physician arrived Sunday.
Scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).
An enzyme found in all living things could be key to fighting deadly parasite-borne diseases, according to a new study. Research into the enzyme, which helps cells convert nutrients into energy, has shown that it is activated in different ways in various species.
A Red Cross team was attacked while collecting bodies believed to be infected with Ebola in southeastern Guinea, the latest in a string of assaults that are hindering efforts to control West Africa's current outbreak.
New estimates by the World Health Organization and the U.S. health agency are warning that the number of Ebola cases could soar dramatically — the U.S. says up to 1.4 million by mid-January in two nations alone — unless efforts to curb the outbreak are significantly ramped up.
A news conference to announce the results of a three-day nationwide shutdown designed to help stop the spread of Ebola has been postponed to give officials who fanned out across the country time to reach the capital.
More than 700 infants may have been exposed to tuberculosis at an El Paso hospital over the past year by an employee recently diagnosed with the illness, health officials said Friday.
A group of international scientists have developed a new method to study Ebola virus in wildlife. The research describes the use of fecal samples from wild great apes to identify populations likely to have been exposed to the virus.
Shoppers in Sierra Leone rushed to stock up on food Thursday ahead of a three-day nationwide shutdown, during which the country's 6 million people will be confined to their homes while volunteers search house-to-house for Ebola victims in hiding and hand out soap in a desperate bid to slow the accelerating outbreak.
The same viruses that make us sick can take up residence in and on the human body without provoking a sneeze, cough or other troublesome symptom, according to new research.
Since the Ebola outbreak first emerged in West Africa, The Associated Press has been reporting on it. A timeline compiled from AP dispatches since March shows the dreaded disease being identified in a remote part of Guinea and then spreading to another country and then two more.
The number of Ebola cases in West Africa could start doubling every three weeks and it could end up costing nearly $1 billion to contain the crisis, the World Health Organization warned Tuesday.
The American strategy on Ebola is two-pronged: Step up desperately needed aid to West Africa and, in an unusual step, train U.S. doctors and nurses for volunteer duty in the outbreak zone.
One of the most rapidly fast-tracked vaccines in history— an anti-Ebola “ChAd3” vaccine— just started clinical trial in humans, and may be done as soon as November. But a second fast-tracked anti-Ebola vaccine— called an “rVSV” vaccine— is hot on its heels.
Mice treated with antibiotics to remove most of their intestinal bacteria or raised under sterile conditions have impaired antibody responses to seasonal influenza vaccination, researchers have found.
The race to stamp out West Africa’s Ebola epidemic is not just about saving lives. It’s also about stemming an assault on society that could include food shortages and mass migration, morphing from a medical emergency into a broad humanitarian crisis.
A pharmacist who worked for a Massachusetts company blamed for a 2012 deadly nationwide meningitis outbreak has pleaded not guilty. Glenn Adam Chin entered his plea to a mail fraud charge at a brief hearing Thursday in federal court in Boston.
Researchers are working to create an online platform that health workers around the world can use to predict where malaria is likely to be transmitted using data on Google Earth Engine. Read more...
A surge in Ebola infections in Liberia is driving a spiraling outbreak in West Africa that is increasingly putting health workers at risk as they struggle to treat an overwhelming number of patients.